Complement C4bC2 complex formation: an investigation by surface plasmon resonance

被引:23
作者
Laich, A [1 ]
Sim, RB [1 ]
机构
[1] Univ Oxford, Dept Biochem, MRC, Immunochem Unit, Oxford OX1 3QU, England
来源
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY | 2001年 / 1544卷 / 1-2期
关键词
human serum; complement; C2; C4; factor B; BIACORE;
D O I
10.1016/S0167-4838(00)00208-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Complex formation between the human complement proteins C4b and C2 was investigated by surface plasmon resonance. C4b was immobilised and C2 was used in the fluid phase to measure interaction at different ionic strengths (30-830 mM NaCl) and in the absence and presence of MgCl2. Maximum binding was observed at 30 mM NaCl, and was negligible above 300 mM NaCl. Binding was not greatly influenced by variation in Mg2+ in the range of 2.5-15 mM. C4bC2 affinity (K-d) was determined by steady-state analysis to be 7.2 x 10(-8) M in physiological conditions (10 mM Hepes, 2.5 mM MgCl2, 0.75 mM CaCl2 and 140 mM NaCl, pH 7.4). For C4(H2O)C2 complex formation, a lih of 4.0 x 10(-8) M was calculated. As far as detected by the applied method, complex formation does not involve conformational changes of one of the binding partners. Consistent with previous reports, C4bC2 binding takes place as a multiple-site binding event in the presence of Mg2+. C4bC2 complex formation in 10 mM Hepes, 2.5 mM EDTA and 140 mM NaCl (pH 7.4) was also observed and the interaction showed characteristics of a single-site binding event. Kd was 1.5 x 10(-8) M. Complement factor B (FB) was also tested for its binding to immobilised C4b. Weak interaction was observed at FB concentrations in the physiological range (500 1000 nM). Kd was 1.2 x 10(-6) M, indicating possible cross-reactivity between classical and alternative pathways of the activation of the complement system. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:96 / 112
页数:17
相关论文
共 35 条
[1]   PRIMARY STRUCTURE OF HUMAN-COMPLEMENT COMPONENT C2 - HOMOLOGY TO 2 UNRELATED PROTEIN FAMILIES [J].
BENTLEY, DR .
BIOCHEMICAL JOURNAL, 1986, 239 (02) :339-345
[2]  
*BIACORE, 1997, BIA EV 3 0 SOFTW HDB
[3]   IDENTIFICATION AND PARTIAL CHARACTERIZATION OF THE SECRETED FORM OF THE 4TH COMPONENT OF HUMAN-COMPLEMENT - EVIDENCE THAT IT IS DIFFERENT FROM MAJOR PLASMA FORM [J].
CHAN, AC ;
MITCHELL, KR ;
MUNNS, TW ;
KARP, DR ;
ATKINSON, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (01) :268-272
[4]  
DODDS AW, 1993, METHOD ENZYMOL, V223, P46
[5]  
HORIUCHI T, 1991, J IMMUNOL, V147, P584
[6]  
Hourcade DE, 1999, J IMMUNOL, V162, P2906
[7]   ANALYSIS OF THE SHORT CONSENSUS REPEATS OF HUMAN-COMPLEMENT FACTOR-B BY SITE-DIRECTED MUTAGENESIS [J].
HOURCADE, DE ;
WAGNER, LM ;
OGLESBY, TJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (34) :19716-19722
[8]   Molecular modeling of ligand and mutation sites of the type a domains of human von Willebrand factor and their relevance to von Willebrand's disease [J].
Jenkins, PV ;
Pasi, KJ ;
Perkins, SJ .
BLOOD, 1998, 91 (06) :2032-2044
[9]   Experimental design for kinetic analysis of protein-protein interactions with surface plasmon resonance biosensors [J].
Karlsson, R ;
Falt, A .
JOURNAL OF IMMUNOLOGICAL METHODS, 1997, 200 (1-2) :121-133
[10]  
KERR MA, 1980, BIOCHEM J, V189, P173, DOI 10.1042/bj1890173